T 1771/19 (Ocular inflammatory diseases/OSAKA UNIVERSITY) of 08.06.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T177119.20220608
- Date of decision
- 8 June 2022
- Case number
- T 1771/19
- Petition for review of
- -
- Application number
- 08792022.9
- IPC class
- A61K 39/00C07K 16/28A61K 31/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient
- Applicant name
- Osaka University
Kyushu University, National University Corporation
Chugai Seiyaku Kabushiki Kaisha - Opponent name
- Regeneron Pharmaceuticals, Inc.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)
- Keywords
- Main request and auxiliary requests 1 to 5 - Amendments - allowable (no)
- Catchword
- -
- Cited cases
- G 0002/10
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.